Category Press Releases

2024-2031 Analysis of Pharmaceutical Processing and Packaging Equipment Market Size, Share, Forecasts, and Trends

The new report, “Pharmaceutical Processing and Packaging Equipment Market: Size, Share, Forecast, and Trends Analysis by Formulation, Secondary Packaging, and End-of-Line Packaging – Global Forecast to 2031,” is now available on ResearchAndMarkets.com. The global pharmaceutical processing and packaging equipment market…

Read More2024-2031 Analysis of Pharmaceutical Processing and Packaging Equipment Market Size, Share, Forecasts, and Trends

New Dupixent and Itepekimab Data at ERS Showcases Respiratory Innovation and Leadership

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that 20 abstracts related to Dupixent® (dupilumab) and the investigational therapy itepekimab will be presented at the European Respiratory Society (ERS) Congress 2024, taking place from September 7 to 11 in Vienna, Austria.…

Read MoreNew Dupixent and Itepekimab Data at ERS Showcases Respiratory Innovation and Leadership

Viatris Unveils Late-Breaking Abstract on Cenerimod at the 26th APLAR Annual Congress

Viatris Inc. (NASDAQ: VTRS), a leading global healthcare company, today presented results from its Phase 2 study of cenerimod (ACT-333441) as a late-breaking abstract at the 26th Asia-Pacific League of Associations for Rheumatology (APLAR) Annual Congress, held from August 21-25,…

Read MoreViatris Unveils Late-Breaking Abstract on Cenerimod at the 26th APLAR Annual Congress

Elanco Animal Health to Expand Production Capabilities at Kansas Manufacturing Facility

Elanco Animal Health Incorporated (NYSE: ELAN) has announced a significant expansion of its biologics manufacturing facility in Elwood, Kansas. The 25,000-square-foot expansion represents a $130 million investment that will be carried out through 2026, aimed at bolstering the company’s monoclonal…

Read MoreElanco Animal Health to Expand Production Capabilities at Kansas Manufacturing Facility

Roche Addresses WHO’s Global Health Emergency Declaration Amid Ongoing Mpox Outbreak

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced its commitment to supporting the global response to the mpox health emergency by providing diagnostic tests specifically developed for mpox, formerly known as monkeypox. The World Health Organization (WHO) declared mpox a Public…

Read MoreRoche Addresses WHO’s Global Health Emergency Declaration Amid Ongoing Mpox Outbreak

EU Approves Second Indication for TEPKINLY in Treating Relapsed/Refractory Follicular Lymphoma

AbbVie (NYSE: ABBV) has announced that the European Commission (EC) has granted conditional marketing authorization for TEPKINLY® (epcoritamab) as a monotherapy for adult patients with relapsed or refractory (R/R) follicular lymphoma (FL) after two or more lines of prior therapy.…

Read MoreEU Approves Second Indication for TEPKINLY in Treating Relapsed/Refractory Follicular Lymphoma

UptimeHealth and Darby Dental Supply Collaborate to Introduce Darby Dispatch: A New Solution for Improving Efficiency and Compliance in Dental Practices Across the Country

UptimeHealth, a leader in healthcare technology solutions, is excited to announce a strategic partnership with Darby Dental Supply, a top dental distributor in the U.S. This collaboration introduces Darby Dispatch, a new tool designed to enhance operational efficiency and compliance…

Read MoreUptimeHealth and Darby Dental Supply Collaborate to Introduce Darby Dispatch: A New Solution for Improving Efficiency and Compliance in Dental Practices Across the Country

Daiwa Health Development, Inc. to Host Webinar with Dr. Fred Pescatore on Clinical Applications of RBAC

Daiwa Health Development, Inc. Announces Webinar with Dr. Fred Pescatore on Clinical Applications of RBAC Daiwa Health Development, Inc. is thrilled to host an upcoming webinar featuring Dr. Fred Pescatore, a distinguished expert in integrative medicine. Scheduled for August 29,…

Read MoreDaiwa Health Development, Inc. to Host Webinar with Dr. Fred Pescatore on Clinical Applications of RBAC

AmorSui Secures $3.5M Seed Funding to Transform Sustainable Medical Supplies

AmorSui, a cutting-edge personal protective equipment (PPE) brand committed to safeguarding both people and the planet, has announced a successful $3.5 million seed funding round. This investment will propel AmorSui’s mission to enhance sustainability, inclusivity, and affordability in the PPE…

Read MoreAmorSui Secures $3.5M Seed Funding to Transform Sustainable Medical Supplies

Agendia Ottiene la Certificazione CE-IVDR per i Test MammaPrint® e BluePrint® sul Cancro al Seno

Oggi, Agendia ha annunciato di aver ricevuto la certificazione dell’Unione Europea (UE) In vitro Diagnostic Medical Device Regulation (IVDR) per tre dei suoi prodotti: MammaPrint® FFPE Microarray, BluePrint® FFPE Microarray e i kit MammaPrint® e BluePrint® NGS. Questi prodotti sono…

Read MoreAgendia Ottiene la Certificazione CE-IVDR per i Test MammaPrint® e BluePrint® sul Cancro al Seno